“We are now dealing with an epidemic worldwide problem of metabolic problems such as diabetes mellitus and high cholesterol. At the same time, we are facing a signficant concern about cardiovascular diseases such as coronary artery disease and hypertension. We have learned a lot about these disorders and we have several good therapies available. But many people are not able to take advantage of these medications for many reasons:
Clinical Study Proven:
Savings:
Proprietary potent combination of select GRAS (generally recognized as safe) with powerful and unique antioxidants that are highly safe and effective:
Berberine is a plant alkaloid with a long history of medicinal use in both Ayurvedic and Chinese medicine. It is present in many plants, including Hydrastiscanadensis (goldenseal), Coptis chinensis (Coptis orgoldenthread), Berberis aquifolium (Oregon grape), Berberis vulgaris (barberry), and Berberis aristata (tree turmeric). Berberine can be found in the root, rhizome,and stem bark of the plants.
Picrorhiza Kurroa is one of the major income generating non-timber forest products found in the Nepalese Himalayas. It is one of the oldest medicinal plants traded from the Karnali zone. Known as Kutki, it is a perennial herb and is used as a substitute for Indian gentian.
Total worldwide cost of managing cardiometabolic diseases now exceeds $500 billion annually.
| Women, % | 61.5 |
| Age, y | 50.0 + 12.5 |
| SBP, mm Hg | 146.6 + 15.3 |
| DBP, mm Hg | 91.1 + 9.7 |
| Waist circumference (cm) | 108.4 + 15.8 |
| Total cholesterol, mg/dL | 226.6 + 39.9 |
| LDL cholesterol, mg/dL | 154.5 + 35.5 |
| HDL cholesterol, mg/dL | 43.0 + 10.0 |
| Triglycerides, mg/dL | 198.3 + 40.5 |
| Glucose, mg/dL | 105.7 + 17.3 |
| Placebo | Essential Cholesterol Burner | |
| Yes | Yes | |
| 1. Reduced hunger between meals | 42% | 96% |
| 2. Feeling more energetic | 57% | 96% |
| 3. Eating less at mealtime | 42% | 100% |
| Placebo | Essential Cholesterol Burner | ||||
| Baseline | 12 weeks | Baseline | 12 weeks | ||
| Waist Circumference (cm) | |||||
| Male | 117 ± 27 | 121 ± 24 | 120 ± 20 | 111 ± 21 | p = 0.082 |
| Female | 108 ± 24 | 103 ± 19 | 110 ± 17 | 105 ± 20 | p = 0.114 |
| Total body fat (percentage) | |||||
| Male | 39.1 ± 6.6 | 39.2 ± 7.0 | 38.1 ± 5.5 | 35.3 ± 5.5 | p = 0.077 |
| Female | 42.2 ± 7.3 | 41.8 ± 6.5 | 42.8 ± 7.0 | 40.0 ± 6.1 | p = 0.098 |
| Placebo | Essential Cholesterol Burner | |||
| Baseline | 12 weeks | Baseline | 12 weeks | |
| Markers of inflammation | ||||
| PAI-1 (mg/ml) | 257 ± 47 | 236 ± 39 | 271 ± 35 | 189 ± 29 * |
| hsCRP (mg/l) | 2.1 ± 0.3 | 2.1 ± 0.4 | 2.4 ± 0.4 | 1.8 ± 0.3 |
| Markers of diabetes and insulin resistance | ||||
| Glutathione redox ratio | 3.0 ± 0.5 | 3.2 ± 0.4 | 3.1 ± 0.5 | 2.6 ± 0.4 * |
| HOMA-IR (index) | 2.3 ± 0.4 | 2.0 ± 0.4 * | 2.3 ± 0.3 | 1.5 ± 0.3 * |
| Direct measurement of vascular function | ||||
| Endothelial FMD | 4.4 ± 0.7 | 4.8 ± 0.4 | 4.3 ± 0.8 | 9.5 ± 0.7 * |
* — value differs (p < 0.05) from baseline and placebo/12 weeks (time and group comparison)
Essential Cholesterol Burner was shown to be very safe and well tolerated in the study population.
No adverse effects on liver function
No adverse effects on renal function
These findings indicate that Essential Cholesterol Burner is a safe and effective agent in impacting individuals who are at risk for:
Essential Cholesterol Burner can be used as adjunctive management or primary management for individuals who are unable or unwilling to take pharmaceutical drugs.
This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
